ENRUHE
PF-Atlas › Clinical Trials › NCT02492867

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Response-driven Adaptive Radiation Therapy · Not specified

Registry ID
NCT02492867
Phase
Not specified
Status
Completed
Drug / intervention
Response-driven Adaptive Radiation Therapy
Sponsor
University of Michigan Rogel Cancer Center
Start
2016-01-14

About this trial

Response-driven Adaptive Radiation Therapy is evaluated in NCT02492867, a idiopathic pulmonary fibrosis study sponsored by University of Michigan Rogel Cancer Center. Current status: Completed.

View NCT02492867 on ClinicalTrials.gov →

Explore related

All Response-driven Adaptive Radiation Therapy trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02492867 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.